Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.74%
1,094.84
+18.71
+1.74%
1,076.131,079.891,100.771,079.89
SIXC
Communications
SIXC
Communications
SIXC
-0.42%
604.21
-2.53
-0.42%
606.74606.74607.90602.03
SIXE
Energy
SIXE
Energy
SIXE
+0.07%
1,249.71
+0.89
+0.07%
1,248.821,246.371,256.421,239.08
SIXI
Industrials
SIXI
Industrials
SIXI
+0.86%
1,739.26
+14.90
+0.86%
1,724.361,733.021,745.751,727.76
SIXM
Financials
SIXM
Financials
SIXM
+0.01%
635.63
+0.040
+0.01%
635.59635.08637.96633.31
SIXR
Staples
SIXR
Staples
SIXR
+0.61%
848.32
+5.17
+0.61%
843.15842.50852.77840.85
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.22%
216.76
+0.47
+0.22%
216.29216.29217.30215.24
SIXT
Technology
SIXT
Technology
SIXT
+2.20%
3,335.14
+71.73
+2.20%
3,263.413,296.253,343.663,295.42
SIXU
Utilities
SIXU
Utilities
SIXU
+0.01%
939.34
+0.10
+0.01%
939.24941.57948.11939.11
SIXV
Health care
SIXV
Health care
SIXV
+0.38%
1,468.17
+5.61
+0.38%
1,462.561,465.031,471.561,459.66
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.28%
2,387.09
+6.69
+0.28%
2,380.402,394.922,412.132,386.82
9989:HKG
Shenzhen Hepalink Pharmaceutical Group Ord Shs H
HK$4.92
+2.93%
(+0.14) 1D
May 6, 4:08:08 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9989...
Open
HK$4.84
High
HK$4.92
Low
HK$4.81
Mkt. cap
16.89B
Avg. vol.
454.87K
Volume
320.50K
Dividend
3.34%
Quarterly dividend
HK$0.04
Ex dividend date
Jul 7, 2025
P/E ratio
18.00
52-wk high
HK$7.26
52-wk low
HK$4.38
EPS
HK$0.27
Shares outstanding
220.09M
No. of employees
2K
News stories
From sources across the web
About Shenzhen Hepalink Pharmaceutical Group Ord Shs H
CEO-
Employees2.15K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.42B
1.38B
1.28B
1.33B
Cost of goods sold
974.82M
884.21M
900.40M
876.31M
Cost of revenue
974.82M
884.21M
900.40M
876.31M
Research and development expenses
62.72M
73.11M
50.33M
36.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.36M
216.50M
252.73M
209.31M
Operating expense
274.56M
291.36M
336.08M
251.72M
Total operating expenses
1.25B
1.18B
1.24B
1.13B
Operating income
173.71M
201.54M
48.03M
202.82M
Other non operating income
-68.37M
182.67M
-254.18M
-137.31M
EBT including unusual items
305.40M
157.96M
-239.36M
207.68M
EBT excluding unusual items
293.42M
188.04M
-97.72M
95.84M
Income tax expense
40.39M
26.52M
-29.37M
20.31M
Effective tax rate
13.23%
16.79%
12.27%
9.78%
Other operating expenses
17.86M
6.60M
16.33M
5.97M
Net income
265.26M
131.73M
-204.09M
187.57M
Net profit margin
18.64%
9.57%
-15.89%
14.09%
Earnings per share
-
-
-
-
Interest and investment income
-
33.52M
-
30.33M
Interest expense
-26.47M
-15.15M
-32.17M
-
Net interest expenses
-26.47M
18.37M
-32.17M
30.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
251.05M
271.82M
128.19M
282.98M
Gain or loss from assets sale
-1.29M
1.29M
-1.84M
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more